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Abstract
Human immunodeficiency virus type 1 (HIV-1) utilizes CD4 as a primary receptor for viral entry and any of several 7-transmembrane
chemokine receptors, including CCR5, as a co-receptor. Previous studies have demonstrated that multiple extracellular domains (ECDs) of
CCR5 contribute to co-receptor function; here we applied genetic footprinting to CCR5 to confirm and extend those investigations. In
genetic footprinting, a duplex oligonucleotide is inserted into the DNA sequence of interest by use of either a bacterial transposase or
retroviral integrase. Here, CCR5 mutants were analyzed in bulk for their ability to be expressed on the recipient cell surface and to mediate
viral entry of R5 HIV isolates. Most of the approximately 150 CCR5 mutants were not expressed on the cell surface. Of those remaining,
8 were specifically reduced or absent after macrophage (M)-tropic HIV infection, confirming a critical role of ECDs three (extracellular loop
2 or ECL2) and possibly four (ECL3) in viral entry. Mutational and functional analyses of ECD4 (ECL3) suggest it is under severe
topological constraint for CCR5 surface expression and are consistent with it contributing to co-receptor function.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Human immunodeficiency virus type 1 (HIV-1), along
with the other primate lentiviruses, utilizes a primary recep-
tor (CD4) and any of a growing number of co-receptors to
mediate viral entry into susceptible cells (for reviews, see
Berson and Doms, 1998; Littman, 1998; and Berger et al.,
1999). The HIV-1 co-receptors belong to the family of
chemokine receptors, 7-pass transmembrane G-protein cou-
pled proteins whose natural functions include stem cell
homing, lymphocyte trafficking, and organ development
(for reviews, see Rossi and Zlotnik, 2000; and Sallusto et
al., 2000). The major co-receptors are considered to be
CXCR4 and CCR5, which function for T cell (T)-tropic
(X4) and macrophage (M)-tropic (R5) HIV isolates, respec-
tively.
Over the last several years, several mutagenesis studies
of CCR5 have been performed, including functional analy-
ses of human-mouse and chemokine receptor chimeric mol-
ecules (Atchison et al., 1996; Rucker et al., 1996; Bieniasz
et al., 1997; Doranz et al., 1997; Picard et al., 1997), ala-
nine-scanning mutagenesis (Dragic et al., 1998; Farzan et
al., 1998; Rabut et al., 1998), and targeted mutagenesis
(Doranz et al., 1997; Ross et al., 1998), although the latter
studies have not been particularly informative. The results
of these investigations have highlighted the importance of
the first extracellular domain (ECD1) of CCR5 (also known
as the amino terminal domain or Nt) for binding to gp120 of
both R5 and dual-tropic (R5X4) viruses (reviewed in Berger
et al., 1999; and Dragic, 2001). For example, chemokine
receptor chimeras utilizing Nt from CCR5 are functional as
R5 co-receptor. In addition, negatively charged (Asp-2,
Asp-11, and Glu-18) and tyrosine residues (Tyr-3, -10, -14,
and -15) are critical for both binding to gp120 and viral
entry. Multiple other residues in ECD1 have also been
demonstrated to contribute to co- receptor function, includ-
ing Ser-6, -7, Ile-9, Asn-13, Gln-21, and Lys-22.
The other ECDs, especially the third (ECD3, also known
as the second extracellular loop or ECL2), contribute to
viral entry, in complex and envelope-specific manners. Gly-
163 (thought to be located in the fourth transmembrane
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domain), Tyr-184, Ser-185, Arg-197, all have been shown
to affect co-receptor function by mutagenesis studies. The
importance of ECD3 for viral entry (but not for gp120
binding) has been buttressed by studies showing inhibition
of virus-cell fusion using monoclonal antibodies that rec-
ognize epitopes in ECL2 (Wu et al., 1997; Lee et al., 1999;
Olson et al., 1999). This suggests that ECD3 may play a role
after gp120 binding to the Nt, perhaps during conforma-
tional changes of CCR5 or co-receptor oligomerization.
Of note, the fourth ECD (ECL3) is absolutely conserved
between man and mouse and has not been subjected to as
extensive mutational analysis. However, limited evidence
suggests the importance of Asp-276 and Gln-280 (Doranz et
al., 1997; Farzan et al., 1998). For the former, reduced
co-receptor function was only observed in the context of
other mutations (namely Asp-11 and/or Arg-197) and only
for R5X4 and not R5 viral envelopes. In fact, in one study
D276A failed to express at detectable levels as measured by
flow cytometry, and cell surface expression of Q280A was
consistently lower than that of wild-type CCR5 (Farzan et
al., 1998). Other point mutations in ECD4 appear to have
little effect on co-receptor function (Doranz et al., 1997;
Farzan et al., 1998). We sought to confirm and extend the
results of the mutagenesis studies by the use of genetic
footprinting.
Genetic footprinting is a saturation mutagenesis tech-
nique in which either a bacterial transposase or retroviral
integrase is used in vitro to randomly insert a duplex oligo-
nucleotide by a concerted integration event into a DNA
sequence of interest (Singh et al., 1997). The entire collec-
tion or library of mutant sequences is then subjected to a
functional selection and analyzed by PCR using a specific
property of the inserted oligonucleotide. This method thus
allows parallel analysis of hundreds if not thousands of
mutants without isolating a single one individually. Genetic
footprinting has been applied with success to the bacterial
suppressor tRNA SupF (Singh et al., 1997), cis acting nu-
cleic acid sequences of the HIV-1 genome (Laurent et al.,
2000), and the Maloney murine leukemia virus (MLV)
envelope glycoprotein (Rothenberg et al., 2001). It has yet
to be used to study the coding sequences of a cellular
eukaryotic gene.
Here we report the application of genetic footprinting to
CCR5. A library of oligonucleotide insertions was made
using MuA transposase in a hemaglutinin (HA) epitope-
tagged version of CCR5 already present in a MLV-based
vector. The library was used to transduce cells bearing CD4
and several functional selections were performed. A major-
ity of the mutant CCR5 proteins were not expressed on the
cell surface, suggesting that membrane trafficking of CCR5
is quite sensitive to its structure. Of the mutants that were
expressed on the cell surface, 8 were still present after
transduction of the cells with HIV pseudotyped with vesic-
ular stomatitis virus (VSV) G protein but greatly reduced in
amount after transduction of cells with HIV pseudotyped
with the envelopes of the R5 isolates ADA, BaL, and
SF162. The location of these insertions confirms the critical
role of the third and possibly fourth ECDs (ECL2 and
ECL3, respectively) for CCR5 co-receptor function, which
was corroborated by specific mutants of the fourth ECD.
These results thus extend the general utility of genetic




Fig. 1 outlines the strategy for genetic footprinting of
CCR5. The gene of interest (CCR5) in an MLV-based
plasmid vector pBabeCCR5-HA (Liu et al., 1996) was sub-
jected to a concerted integration reaction in vitro using
purified MuA transposase (Fig. 1A, B). After oligonucleo-
tide addition, the resulting DNA was cut with Mlu I, reli-
gated, and transformed into E. coli. Approximately 4.5 
105 bacterial colonies were pooled and plasmid DNA pre-
pared. Randomness of integration was confirmed by digest-
ing the DNA with both Not I (cleaves the vector backbone
once) and Mlu I, which resulted in a smear of DNA frag-
ments as judged by horizontal agarose gel electrophoresis.
Greater than 95% of the plasmids had a single Mlu I site.
Note that the coding sequence of CCR5 is only approxi-
mately 1.1 kb in length, so roughly 17% of the oligonucle-
otide inserts were inserted within CCR5 (the rest within
vector sequences).
Purified plasmid DNA along with pHIT60 (encodes
MLV Gag-Pol) (Soneoka et al., 1995), and pMEVSV G
(encodes VSV G) (Sutton et al., 1998) was used to tran-
siently transfect 293T cells (Fig. 1B). The resulting
pseudotyped viral supernatants were titered on HOS.T4
cells by end- point dilution, and the titers were approxi-
mately 6  104 IU/ml. Forty milliliters of viral supernatant
(2.4  106 IU) were used to transduce 5  107 HOS.T4
cells so that the MOI was .05 and double transductants
would be avoided. This low MOI was important to reduce
any type of trans-complementation in the targets. At the
same time, since this amount of IU represents only 1000
MLV vector clones (see below), each is represented on
average 2400-fold. Even if some are under-represented 50-
fold, those clones would still be represented by 50 differ-
ent transduction events, thus greatly reducing or eliminating
any clonal bias in transgene expression which is well-
known to occur after retroviral transduction. After puromy-
cin selection, cells were pooled, washed, expanded for sev-
eral weeks, and frozen in aliquots of at least 107 cells to
avoid bottle-necking and loss of representation. These cells
were then used for functional tests.
Fig. 1C demonstrates the principle behind genetic footprint-
ing. The gene of interest has in each case no more than a single
duplex oligonucleotide inserted at a random position. Using
two PCR primers (one labeled with P-32 and the other one
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Fig. 1. Schematic of genetic footprinting. (A) shows MuA transposase-mediated concerted integration of the duplex oligonucleotide containing the M1u I site into the gene
of interest contained on plasmid DNA. Note, however, that the integration event may occur anywhere in the plasmid DNA. (B) shows the MLV-based vector encoding
HA-tagged CCR5. This was subjected to concerted integration and the plasmid library was co-transfected into 293T cells to produce VSV G-pseudotyped MLV particles
(shown with a diploid RNA genome), which were then used to transduce HOS T4 cells. The puroR cells were then sorted and subjected to functional selections. (C) shows
the basic principle of the PCR technique to determine the point of oligonucleotide insertion. The oligo is represented by a closed box (region where function is not disrupted)
or open box (function is disrupted). B biotin, UN unselected population, SEL selected population. (D) shows some of the functional selections performed here. At
top are HOS.T4 cells, each with a single MLV integrant. Within the nucleus is the HA tagged CCR5 gene, with the inserted oligonucleotide as a black box. Note after sorting
for surface expression, CCR5 (grey circles) is on the cell surface. After infection with HIV- blasti (ADA), only one of the cell clones remains. At bottom is a schematic of
the denaturing polyacrylamide gel, showing idealized results, with square brackets indicating regions of functional importance.

biotin), the appropriate PCR product is amplified, isolated, and
in this case subjected to Mlu I restriction endonuclease cleav-
age. Restriction digest products are separated on a denaturing
polyacrylamide sequencing gel and exposed by autoradiogra-
phy. All insertions will be revealed in the unselected material.
Once a functional selection has been applied, some products
will no longer be present, thus delineating the region of the
gene required for function (bracket in Fig. 1C).
This strategy as applied to CCR5 is shown in Fig. 1D.
The pooled puromycinR HOS.T4 cells described above
were expanded and then first sorted by magnetic beads
using the anti-HA epitope antibody 12CA5. Positively
sorted cells were expanded and divided. These cells were
then subjected to transduction to the following vector su-
pernatants separately: HIV-blasti (VSV G), HIV-blasti
(ADA), HIV-blasti (BaL), and HIV-blasti (SF162). In each
case at least 106 IU were used, as titered on HOS.T4.CCR5
cells. VSV G was used as a control since VSV uses phos-
photidylserine and not CCR5 as its cellular receptor, and the
latter three are all M-tropic (R5) envelopes that utilize
CCR5. As a negative control, the titer of HIV-blasti (HXB2)
was less than 10 IU/ml on HOS.T4.CCR5 cells.
After blasticidin selection, resultant colonies were
pooled, expanded, and genomic DNA prepared. Anticipated
results are shown at the bottom of Fig. 1D. As expected,
there were no changes in the pattern of the radioactive PCR
products when comparing the initial plasmid DNA pool to
that of the post-MLV transduction of the HOS.T4 cells (data
not shown). However, there was marked loss of products
after sorting for surface expression of CCR5 (see below).
This loss would thus define regions important for cell sur-
face expression of CCR5. Unexpectedly, there was some
additional loss of bands after HIV-blasti (VSV G) transduc-
tion (see below). However, there was additional product
loss after transduction of the R5 envelope-bearing viruses
(see below). This loss would define regions or amino acid
residues critical for infection with these R5 viruses.
Determination of the point of insertion of the
oligonucleotide
Fig. 2A illustrates the different reading frames of the in-
serted oligonucleotide. The Mlu I site is centrally located
within the new 10 bp insertion and the 5 bp duplication. This
Fig. 2. Inserted oligonucleotide and PCR strategy. (A) shows for each of the three reading frames the resultant codons of the inserted 10 bp oligonucleotide
and the 5 bp (N1–N5) flanking sequence duplication. The M1u I recognition site is underlined and the precise cleavage positions are indicated by vertical
arrows. Since  90% of the insertions have 5 bp duplications, the downstream reading frame is maintained (except, of course, when a stop codon is
introduced). (B) At top is a schematic of the CCR5 open reading frame. For the nested PCR, the initial set of primers was in vector flanking sequence. Five
pairs of PCR primers were used in separate, second PCR reactions. Note there is significant overlap between all except for the last two. Dotted lines indicate
length of the initial and final PCR products, and none of the latter was greater than 450 bp in size. Primers and products are approximately to scale.
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5–5 bp duplication occurs greater than 90% of the time for the
concerted MuA transposase in vitro integration reaction (R.
Crowley and P.O. Brown, unpublished results). Thus a total of
15 bp are inserted so that the reading frame is maintained.
Unfortunately, unavoidable DNA recognition sequence con-
straints of the MuA transposase imposed a stop codon (TGA)
if the oligonucleotide was inserted in frame. This would then
lead to protein truncation at the point of insertion. Note that for
the other two reading frames the predicted codons would lead
to incorporation of a mix of hydrophobic, basic and acidic
amino acid residues. In both cases there would also be dupli-
cation of one residue. It is also important to realize that as
shown in Fig. 2A the insertion point can either be considered
to be at position N5 or N1. Both interpretations are technically
correct, but since proteins are translated starting at the amino
terminus we have regarded N5 to be the insertion point and the
second N1–N5 the duplicated sequence.
When determining the point of oligonucleotide insertion,
the same radioactive DNA primer was used in both the PCR
and the Sanger sequencing reaction and the homologous DNA
sequence was electrophoresed on neighboring gel lanes. Note
that when the upper (5) PCR primer was radioactive, after
Mlu I digestion the radioactive product was 3 bp longer than
the point of insertion, and in the case of the lower (3) PCR
primer, the radioactive product was 8 bp longer than the true
point of insertion (N5 in Figure 2A). From the original plasmid
library we isolated approximately 10 mutants and sequenced
the site of oligonucleotide insertion. In all of the examined
mutants, the expected 5 bp duplication was present at the point
of insertion. Although none of the mutants were informative
(i.e., they were lost after bulk cell-surface sorting), the point of
insertion agreed with that determined by the PCR and dena-
turing sequencing gel method.
Fig. 2B illustrates the PCR strategy. Using the genomic
DNA, an initial product of 1.4 kbp was amplified using the
external primers. This 1.4 kbp product was used in nested
PCR reactions, with the approximate positions of the primer
pairs and product sizes as shown. There is overlap between
all PCR products (although somewhat minimal between
products 4 and 5) and no product is longer than approxi-
mately 450 bp. Thus, the point of insertion could be iden-
tified in each PCR product by switching the position of the
radioactive and biotinylated primers and performing two or
three loads on a 40 cm denaturing polyacrylamide sequenc-
ing gel. In the regions of the PCR product where the point
of insertion could be read using either radioactive primer,
the two results agreed perfectly, confirming the 5–5 dupli-
cation rule as described above.
Multiple regions of CCR5 contribute to surface membrane
trafficking
After transduction of the mutant CCR5 library into
HOS.T4 cells, cells were magnetic bead-sorted for surface
expression of CCR5. Sorted cells were expanded and trans-
duced with the different vector supernatants as described
above. To confirm that the mutant CCR5 proteins were
actually being expressed on the cell surface, we performed
flow cytometry on the different populations. As shown in
Figure 3A, 30% of the unsorted cells were judged to be
positive, whereas after sorting and the different transduc-
tions between 52% and 84% were positive. We are at a loss
to explain why these numbers are low (i.e., not 100% after
R5 viral infection), but it appears to be due to insufficient
increase in mean cell fluorescence after antibody staining
(see Figs. 3E and 3F).
Because we had noted extensive band loss or “dropout”
after magnetic bead sorting in preliminary experiments, we
became concerned about loss of representation or “bottle-
necking” despite the fact that 4  107 cells had been sorted.
We thus sorted three batches of cells in parallel and per-
formed genetic footprinting on the genomic DNA. Fig. 4
shows that essentially the same band dropout was observed
with all three sorted samples (compare unsorted vs. sorted-
1,2,3). This result was confirmed with two other primer
pairs (data not shown). Thus, the differences that we had
initially observed between the sorted and unsorted popula-
tions were unlikely to be due to misrepresentation but in-
stead to true dropout, consistent with loss of function.
This extensive band loss was observed with other primer
pairs throughout CCR5 (Fig. 5 and 6 and data not shown),
suggesting that cell surface expression of CCR5 was quite
sensitive and easily disrupted by the 15 bp oligonucleotide/5
amino acid residue insertion. As summarized in Fig. 7, out
of a total of 148 oligonucleotide insertions (excluding
known insertions within the HA epitope), only 53 (36%)
were consistently observed in the sorted population. Note
many oligonucleotides (37) were inserted in frame to create
a truncated gene product and were only present in the
unsorted population (grey residues in Fig. 8). These were
present in ECDs 1, 3, and 4, all transmembrane regions, and
most of the intracellular domains.
There were also many oligonucleotide insertions (58)
that were out of frame but still disrupted surface expression
of CCR5 and thus were not present within the sorted pop-
ulation (see Fig. 7 and red residues in Fig. 8). These inser-
tions were present in all extracellular, transmembrane, and
intracellular domains of CCR5. This suggests that the
7-transmembrane topology or cell surface trafficking of
CCR5 is quite sensitive to a small 5 amino acid residue
insertion, even if it is completely within an intracellular or
extracellular domain.
A number of oligonucleotide insertions (15, equivalent to
10% of the mutants) were present in the sorted and unsorted
populations but not in the post-HIV(VSV G) transduction
population (see Figures 4–6 and green residues in Fig. 8).
It is possible that this reflects mutant loss prior to HIV(VSV
G) infection since these insertions were also absent in all
three of the post-R5 transduction populations. The great
majority of these insertions (13/15) were in the transmem-
brane regions. Whether these mutants somehow represent
PCR artifacts or perhaps disruption/modification of the cell
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surface membrane such that not even VSV G pseudotypes are
infectious is unknown; since these mutants were not present in
any of the post-infection populations they did not contribute to
or interfere with the analysis of CCR5 function.
CCR5 is tolerant to oligonucleotide insertions
It was already known that short peptide epitopes could be
placed within the first ECD of CCR5 and still retain co--
receptor function. For example, the starting CCR5 construct
for these investigations has an eight amino acid HA epitope
tag inserted at residue 14 (Liu et al., 1996). However, even
placement of this epitope proved difficult since the impor-
tance of the tyrosine residues in that first domain were
unappreciated at the time of vector construction (N. Landau,
personal communication). This genetic footprinting proce-
dure also identifies points of oligonucleotide insertion that
Fig. 3. Cell surface expression of CCR5. The six different HOS.T4 cell populations were analyzed by flow cytometry using an indirect method for surface
expression of CCR5. (A) Post-MLV transduction and unsorted, (B) post-magnetic bead sorted, (C) post-HIV (VSV G) transduction, (D) post-HIV (ADA)
transduction, (E) post-HIV (BaL) transduction, and (E) post-HIV (SF162) transduction. Grey histograms: goat anti-mouse-FITC (GAM-FITC) alone added,
black histograms, 12CA5 and GAM-FITC added. Bars and percentages indicate positive population (gated at 1% background).
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Fig. 4. Genetic footprinting of CCR5, region 406–716. Genomic DNA was prepared from the cell populations shown in Figure 3 and nested PCR performed.
In this case, the 627U primer was labelled with P-32. After M1u I digestion, products were size fractionated on a denaturing polyacrylamide gel along with
the homologous sequence and subjected to autoradiography. Sorted-1, Sorted-2, Sorted-3 are the three cell samples sorted in parallel for surface CCR5
expression. * is the full-length, undigested PCR product (311 nt), closed arrowheads indicate products observed in the unsorted population only, and open
arrowheads indicate products observed in the sorted population as well. Refer to Figure 7 for bp numbering.
Fig. 5. Genetic footprinting of CCR5, region 60–496. Here, the 693B primer was labeled with P-32. Please refer to Figure 4 for experimental details and
legend key.
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are tolerated by CCR5 (depending upon the required func-
tional tests, of course).
Multiple oligonucleotide insertions (26) were present in
all the cell populations analyzed: unsorted, sorted, post-
HIV(VSV G), and post-R5 viral transductions (see Figs.
4–6 and blue residues in Fig. 8). Surprisingly, nearly half of
these were in the transmembrane regions. There were 0–2
insertions in most of the extracellular and intracellular do-
mains, with the exception of the cytoplasmic tail, where
there were 6 tolerated oligonucleotide insertions. This is not
unexpected, since the cytoplasmic tail is not required for
co-receptor function (Alkhatib et al., 1997) and C-terminal
green fluorescent proteins are fully active (D. Littman, per-
sonal communication). Whether all of these would be still
be present if other functional tests were to be applied (e.g.,
calcium/cellular signalling, chemokine binding, or cellular
chemotaxis) is unknown.
Residues in the third and fourth ECD are critical for
CCR5 co-receptor function
Of the 148 mutant CCR5 proteins, only 8 were present in
the unsorted, sorted, and post-HIV(VSV G) genomic DNA
material, but reduced or absent in the post-R5 envelope
genomic DNA. These oligonucleotide insertions were found
within the third ECD (ECL2), the fourth transmembrane
region, and the third intracellular loop (Figure 4 and yellow
residues in Figure 8). The first Cys in the third ECD (residue
184 here) is thought to make a critical disulfide bond link-
age with the Cys in the second ECD (residue 107 here, see
Figure 8). This bond is likely important for the proper
folding and function of CCR5. Note one oligonucleotide
insertion at C184 led to protein truncation and was only
present in the unsorted population, whereas the other inser-
tion was at bp 551 and was specifically absent from the
post-R5 envelope transduction populations (Figure 4). This
insertion results in the amino acid sequence . . . Tyr-Thr-
Cys-Asp-Ala-Ser-Thr-Cys-Ser-Ser . . . , where the under-
lined portion are the novel residues. Although it appears to
be expressed on the cell surface, this protein may be mis-
folded because of the presence of a second Cys or alterna-
tively critical determinants for CCR5 co-receptor function
may be disrupted by this insertion.
The second oligonucleotide insertion specifically re-
duced in the post-R5 envelope transduction populations was
within the Tyr residue 193. This insertion results in the
amino acid sequence. . . . Ser-Gln-Leu-Thr-Arg-His-Gln-
Tyr-Gln . . . , where the novel residues are underlined. Al-
though expressed on the cell surface, this mutant CCR5 was
reduced by 90% after HIV(ADA), HIV(BaL), and
HIV(SF162) transductions. Presumably it too disrupts crit-
ical co-receptor determinants.
The third and fourth oligonucleotide insertions specifi-
cally reduced in the post-R5 envelope transduction popula-
tions led to truncated proteins after the Trp residue 196 and
the Gln residue 200, respectively. Since both of these pro-
Fig. 6. Genetic footprinting of CCR5, region 686 to C-terminus. In this
case, the 907U primer was labelled with P-32. Please refer to Figure 4 for
experimental details and legend key. Grey arrowheads indicate insertions
3 of the stop codon at position 1075.
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teins were expressed on the cell surface, they likely have
altered conformations that will not support co-receptor
function. Alternatively, there may be critical determinants
of co-receptor function that are C-terminal to these residues
(see below).
The fifth and sixth oligonucleotide insertions variably
present within the post-R5 envelope transduction popula-
tions were at nucleotide positions 649 and 650 within the
Val residue 217 (thought to lie within the fifth transmem-
brane domain) (Figs. 4 and 8). These insertions gave rise to
inserted peptides. . . . Val-Met-Val-Thr-Arg-His-Met-Val-
Ile. . . . and. . . . Val-Met-Val-Asp-Ala-Ser-Met-Val-
Ile. . . . , respectively, where the underlined portion is the
novel sequence. It is possible that the presence of the single
charged residue (Arg or Asp) within the transmembrane
domain disrupted conformation to such an extent these were
reduced in the R5 envelope populations (despite the fact
they are trafficked to the cell surface).
The seventh and eighth oligonucleotide insertions absent
within the post-R5 envelope transduction populations were
at positions 688 and 691 (Fig. 4). These insertions led to
protein truncations after amino acid residues Arg 229 and
Cys 230, respectively (third intracellular domain, Fig. 8).
These insertions were somewhat unusual in that they were
present in the unsorted population, consistently reduced in
the post-sorted population, quite prominent in the post-
Fig. 7. Points of insertion of the oligonucleotide. Closed arrowheads indicate products only observed in the unsorted population, and open arrowheads indicate
products observed in the sorted population as well. Bold type indicates the HA tag. Note the first residue of the epitope (Y) is also part of CCR5. In addition,
two residues (Y15 and T16) of wild-type CCR5 were removed during the addition of the epitope, which did not appear to compromise co-receptor function.
Underlined residues indicate putative transmembrane domains.
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HIV(VSV G) transduction population, and virtually absent
in all three of the post-R5 transduction populations (Fig. 4).
It is unknown whether C230 forms a disulfide bond with
any of the other intracellular Cys residues. These two oli-
gonucleotide insertions both suggest that there are critical
CCR5 co-receptor determinants C-terminal to C230, quite
possibly within the fourth ECD.
To address this question more directly, we made several
mutations in the highly conserved fourth ECD (Table 1).
Some of these added one to a few residues, others deleted a
few to most of the ECD. Of note, only one of the mutants
was expressed on the cell surface (4ECD-6), although the
percentage of positive cells, as judged by flow cytometry,
was reduced 20-fold compared to wt control (Fig. 9). The
positive mutant CCR5 cells, however, had the same, if not
greater, mean fluorescence intensity (MFI) as wt control,
whereas the titer of HIV-Neo (ADA) on 4ECD-6 expressing
cells was reduced more than 5,000-fold compared to wt
control (Table 1).
Discussion
Utility of genetic footprinting
We have described here the use of genetic footprinting to
analyze the function of a cellular eukaryotic gene. Previously,
the use of this technique has been confined to the study of a
bacterial suppressor tRNA, the cis-acting sequences of the HIV
genome, and a retroviral envelope. The study of CCR5 co-
receptor function adds a level of complexity since specific
amino acid residues were introduced and multiple complex
functional assays performed. Because we were analyzing in-
sertions in mammalian genomic DNA, the use of PCR was
unavoidable and we cannot exclude representational bias after
nested amplification. However, when comparing nested PCR
performed on the original plasmid DNA pool vs. the genomic
DNA of the unsorted population, there was no clear represen-
tational loss or gain, suggesting that the points of oligonucle-
otide insertion and their relative intensities after PCR reflect
Fig. 8. Schematic of CCR5 structure. Plasma membrane is indicated by the curved cyan lines; ECDs are at top, intracellular loops at bottom (amino and
carboxy termini indicated). Black residues indicate the HA epitope tag, grey residues truncations at that position present only in the unsorted population, red
residues non-truncating insertions at that position present in the unsorted population only, blue residues insertions at that position present in all populations,
green residues insertions at that position present in the unsorted and sorted populations only, and yellow residues insertions at that position present in the
unsorted, sorted, and post- HIV(VSV G) but absent in the post-R5 envelope populations. Split circles indicate multiple insertions at that residue.
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their true frequencies in the cell population and the correspond-
ing genomic DNA.
After the initial amplification step, each region of the gene
is subjected to PCR by a single set of primers under the same
conditions and later digested with Mlu I; it is thus hard to
ascribe the varying band intensities to PCR artifact. Increased
or decreased intensity of any single cleaved PCR product most
likely represents over and under-representation of that mutant
in the library (as has been observed in other MuA transposase-
generated libraries; see Laurent et al., 2000), respectively,
although we have not formally shown that since our library
sampling of specific mutants here was only 6%.
The original mutant plasmid library had 450,000 mem-
bers and was not liquid or plate amplified. Due care was
exercised to avoid loss of representation or “bottlenecking”
by working with a large number of cells and pseudotyped
particles at each step along the way (including the amount
of genomic DNA for the nested PCR). It appears however,
that the true complexity of the library was only 1000
members. Thus, instead of 70 oligonucleotide insertions
per bp of the plasmid pBabeCCR5HA, on average there was
1 oligonucleotide insertion per 6 bp. Precisely why the
library was 500-fold less complex than expected is a matter
of speculation. It is unlikely to be due to loss of represen-
tation secondary to the multiple manipulations performed
since the original mutant plasmid pool also demonstrated
this frequency of oligonucleotide insertion. Rather, it may
be due to the known marked site preference of MuA trans-
posase, the bacterial integrase used here, which is reflected
in the varying band intensities of the original library.
Table 1
CCR5 fourth extra-cellular domain mutants
Mutanta Expressionb Titerc
wt ECD4
aac acc ttc cag gaa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct atg  5000
N T F Q E F F G L N N C S S S N R L D Q A M
4ECD-1
aac acc ttc cag gaa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct ggg cat atg  ND
N T F Q E F F G L N N C S S S N R L D Q A G H M
4ECD-2
aac acc ttc cag gaa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct cat atg  ND
N T F Q E F F G L N N C S S S N R L D Q A H M
4ECD-3
aac acc ttc cag gaa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct cat atg  ND
N T F Q E F F G L N N C S S S N R L D Q A H M
4ECD-4
aac acc ttc cag gaa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct atg  ND
N T F Q E F F G L N N C S S S N R L D Q A M
4ECD-5
aac acc ttc cag gaa ttg tcg act gaa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct atg  ND
N T F Q E L S T E F F G L N N C S S S N R L D Q A M
4ECD-6
aac acc ttc cag gaa ttc agt cga caa ttc ttt ggc ctg aat aat tgc agt agc tct aac agg ttg gac caa gct atg   1
N T F Q E F S R Q F F G L N N C S S S N R L D Q A M
a Bold residues indicate those added, boxed residues those deleted (compared to wt) from the fourth ECD, all sequence-confirmed.
b Relative cell surface amounts, as judged by flow cytometry using an anti-CCR5-PE monoclonal antibody.  denotes 20–40%, 1–3%, and  
0.1% positive cells.
c IU/ml, using HIV-Neo (ADA) as determined on HOS cells also expressing CD4; ND not determined. For both wt and 4ECD-6, the HIV-IRES-eYFP
(VSV G) titers were the same (107 IU/ml).
Fig. 9. Flow cytometry of HOS.CD4.CCR5 cells. HOS.CD4 cells were transduced with an MLV vector encoding either wt (A) or mutant ECD4-6 (B) CCR5.
After puromycin selection, cells were stained for CCR5 using PE conjugated antibody. Gate was set so that  0.1% of HOS.CD4 cells were positive (not
shown). Percentage of gated cells and MFI (calculated as distance from origin) for each are indicated.
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This insertional bias was previously observed when an-
alyzing the cis-acting elements of the HIV genome, where
the original library had similar complexity to the one de-
scribed here and yet the frequency of oligonucleotide inser-
tion was approximately 1 every 7 bp (Laurent et al., 2000).
Similar bias was observed in the study of ecotropic MLV
envelope (Rothenberg et al., 2001). The retroviral integrases
do not appear to have such marked site preferences when
naked DNA is used as a template (Brown et al., 1987;
Pryciak and Varmus, 1992; Singh et al., 1997). Unfortu-
nately, they are also more difficult to purify in soluble active
form and have less intrinsic concerted integration enzymatic
activity in comparison to MuA transposase.
We also endeavored to simplify genetic footprinting by
not attempting to subclone the integration product but in-
stead left it in the MLV-based vector. Previously, the inte-
gration products were cloned into a small plasmid vector or
into the HIV genome (present within a plasmid vector).
Thus, each member of the mutant plasmid library would
have at most a single oligonucleotide insertion only within
the region of interest but construction of the library is more
laborious. Here, 15–20% of the members of the mutant
plasmid library had a single oligonucleotide insertion within
the coding sequence of CCR5 (the rest had none), but the
library was relatively easy to construct since the linear
concerted integration product was simply recircularized.
Thus, to attain the same complexity as the subcloned li-
brary, the direct library would have to be 5-fold greater in
size in this specific case. But since the true complexity of
these libraries was only a few thousand (see above), this is
readily accomplished. Achievement of equivalent complex-
ity will obviously depend upon the size of both the plasmid
and the region of interest. Direct libraries might be favored
when the region of interest is large and the plasmid is small,
whereas subcloned libraries are preferred when the region
of interest is small and the plasmid large.
As in other studies using genetic footprinting, we did not
attempt to reconstruct any of the specific CCR5 mutants in
the library. Even with a complexity of only 1000 members,
direct isolation of the mutants of greatest interest would be
non-trivial, and as mentioned above the specific mutants
isolated here were unfortunately all non-informative. Re-
construction of select mutants would also be difficult (al-
though not impossible). Indeed, the strength of this method
lies in the fact that the mutants are not analyzed individually
but in bulk. When working well, the technique of genetic
footprinting should allow the parallel analysis of thousand
of mutants in any of a number of functional selections,
limited only by the parameters of the biological system (see
below).
Genetic footprinting is non-trivial. Complexity of the
analyses grows substantially as the region of interest be-
comes larger and as the number of functional analyses
increases. Cleaner results are obtained when the functional
selection is strong. Sorting for surface expression as de-
scribed here is a moderately strong functional selection,
although there is an unavoidable background (see Figure 3).
Survival after lentiviral transduction is a strong functional
selection since the untransduced cells die and the transduced
cells are expanded logarithmically (and the background is
almost non-existent). We did not attempt other functional
selections of CCR5 such as G-coupled calcium signaling,
chemokine ligand binding, or cellular chemotaxis since
those selections are likely to be considerably weaker and not
absolute.
Cell surface expression of CCR5
It is perhaps not surprising that approximately two-thirds
(64%) of the oligonucleotide insertions resulted in a protein
that did not get trafficked to the cell membrane, especially
since many led to premature truncation. The well-known
	32 allele causes a frame-shift mutation and a premature
stop codon within the third ECD, resulting in a protein that
is expressed in the cell but not on the cell membrane (Liu et
al., 1996; Samson, 1996). What is more surprising is that
half of the insertions reported here were in either the puta-
tive extracellular or intracellular domains, and half within
the transmembrane regions (approximating the distribution
of residues). This counter-intuitive result suggests that the
topological constraints of the 7-transmembrane proteins
might be much greater than previously thought.
Of course, insertion of five amino acids any where in
CCR5 might greatly disturb trafficking or function (reflect-
ed here in the few mutants that survived the cell sorting).
Efforts to develop “replacement” instead of “insertion” ge-
netic footprinting libraries, in which a type II restriction
enzyme (e.g., Bsg I) is used to recircularize the plasmid
after the concerted integration reaction, are underway. Be-
cause a few residues are simply replaced with an equivalent
number, the mutagenesis should be less disruptive to overall
protein topology and structure.
It is instructive to examine the insertions that were ac-
tually tolerated. Surprisingly, most (87%) of the ones
present in the sorted and unsorted populations were present
in the predicted transmembrane domains, again underscor-
ing how little is known regarding the conformational re-
quirements of CCR5. This is despite the fact that the inser-
tion invariably leads to the addition of one or two charged
residues (see Figure 2A). This was also true for the inser-
tions present in all the cell populations, although there was
a slight bias towards insertion in the carboxy terminal cy-
toplasmic domain (5 out of 50 compared to 21 out of 308).
Note there were fully tolerated insertions in each of the four
ECDs (Nt and ECL1–3), suggesting possible placement of
additional epitope tags. This may be useful for structural
studies using antibody reagents and fluorescence resonance
energy transfer.
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Co-receptor function of CCR5
Of nearly 150 insertions in CCR5 analyzed here, only a
minority was informative regarding co-receptor function.
Previous investigations had identified critical residues
throughout CCR5, especially in the first ECD (Dragic,
1998; Farzan et al., 1998; Ross et al., 1998). Unfortunately,
in that region (Nt) only a single insertion at K32 was
informative here, and that was present in all populations.
Thus, conclusions here are limited to examination of the
informative mutations in the other domains. Of interest is
the insertion in C184, which likely forms a covalent disul-
fide bond with C107 (Berger et al., 1999). C184 is recreated
upon the oligonucleotide insertion, but the downstream res-
idues are altered (see above). S186, which had been previ-
ously identified by substituting mouse residues into human
CCR5 as being critical for co-receptor function (Ross et al.,
1998), thus shifts position by five residues. In addition,
other previously identified critical residues just C-terminal
to S186, notably P189, Y190, and S191 (Kuhmann et al.,
1997; Ross et al., 1998), would also be shifted by the same
amount. It may thus be difficult to separate direct from
indirect effects of the insertion at C184.
The same is true for the other three insertions (Y193,
W196, and Q200) in ECL2 that specifically affected co-
receptor function. The latter two resulted in protein trunca-
tions, which may have disrupted the loop structure or elim-
inated downstream determinants. For example, K203A
enhances the D11A loss-of-function mutation for R5X4
envelopes (Doranz et al., 1997). No co-receptor function
had previously been assigned to Y193. The effect observed
at that residue may be direct or indirect, considering that it
is a closed loop. There must be some flexibility in this loop
structure, however, because insertions at R174 and E178
were well tolerated.
Can any conclusions be drawn from the truncating mu-
tations at R229 and C230? The two major possibilities are
that these truncating mutations are either structurally desta-
bilizing (despite the fact they are expressed on the cell
surface) or there are co-receptor determinants C-terminal, in
the fourth ECD (ECL3). With regard to the latter, the CCR5
chimera studies have not been informative since the mouse
sequence is identical to that of the human. Alanine-scanning
mutagenesis has demonstrated the importance of D282 (in
the context of D11A) for R5X4 strains (Doranz et al., 1997).
This effect was not observed for the R5 strain JR-FL,
although it is clear that the fourth ECD alone (in the context
of murine CCR5) is insufficient for co-receptor function
(Bieniasz et al., 1997). Of the mutants in the fourth ECD
that we examined here, only one (4ECD-6) was informative
in the sense that it was actually present on the cell surface.
Minimal disruption of that loop (e.g., addition of one resi-
due) led to undetectable surface expression. Based upon
flow cytometry, 4ECD-6 was expressed on the cell surface,
and although the percentage of positive cells was reduced
20-fold compared to wild-type, the amount of expression on
a per cell basis (as quantitated by MCF) was the same, if not
higher. Thus, the fact that M-tropic viral titers were reduced
approximately four log10s is consistent with ECL3 playing
a role in co-receptor function and probably deserves further
exploration.
Previous investigations with mouse-human CCR5 chi-
meras revealed differing requirements for the extracellular
loops for strains ADA, SF162, and BaL, with BaL being the
most sensitive to the presence of murine sequences (Bien-
iasz et al., 1997; Picard et al., 1997). To a first approxima-
tion, we did not observe substantial differences between the
three envelopes studied here, and whether that reflects the
nature of the insertional mutagenesis versus the sensitivity
of the PCR assay is unknown.
In summary, this report describes the application of ge-
netic footprinting to the HIV co-receptor CCR5. Although
the density of the insertion oligonucleotides was lower than
expected, the important conclusions are that surface expres-
sion of CCR5 is relatively intolerant to 5 amino acid residue
insertions, and critical co-receptor determinants lie within
ECL2 and possibly ECL3. This is consistent with previous
investigations using envelopes of R5 HIV isolates. It is
entirely conceivable that a denser insertion library or alter-
natively a replacement genetic footprinting library may be
more illuminating, depending upon the topological con-
straints of the gene under study.
Materials and methods
Plasmids
HIV-1 envelope expression plasmids pSM-ADA, pSM-
BaL, and pSM-SF162 were gifts of Dan Littman (Skirball
Institute, NYU Medical Center). MLV Gag-Pol expression
construct pHIT60 (Soneoka et al., 1995) and pBa-
beCCR5-HA (Liu et al., 1996) were obtained from Alan
Kingsman (Oxford) and Ned Landau (Salk Institute), re-
spectively. HIV-blasti and HIV-Neo were constructed by
substituting the coding region of alkaline phosphatase of the
vector pHIV-AP	env	vif	vpr (Sutton et al., 1998) with
that of either the blasticidin resistance gene from pcDNA6/
V5-HisA (Invitrogen) or SV-Neo (from pBabeNeo), respec-
tively. HIV-IRES-eYFP has been reported previously
(Schroers et al., 2000), as has the VSV G expression plas-
mid pME VSV G (Sutton et al., 1998).
Oligonucleotide insertion library of CCR5
Purified MuA transposase (gift of Harry Savilahti) was
used to create a library of insertional mutations in pBa-
beCCR5-HA using modifications of described methods
(Singh et al., 1997; Lauren et al., 2000). The donor oligo-
nucleotide duplex used to create the insertions contained the
recognition sequences for both the MuA transposase and
MluI restriction endonuclease. This duplex was generated
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by annealing together the oligonucleotides MuAMlu15A
(5-TGACGCGTCGCACGAAAAACGCGAAAGCGTTTC-
ACGATAAATGCGAAAAC-3) and MuAMlu15B (5-GTT-
TTCGCATTTATCGTGAAACGCTTTCGCGTTTTTCG-
TGCGACGCGTCA-3). The transposition reaction was
performed by incubating 50 nM donor oligo duplex, 10 g
pBabeCCR5-HA, and 100nM MuA transposase in a buffer
containing 25 mM Tris–HCl pH 8.0, 144 mM NaCl, 10 mM
MgCl2, 100 g/ml bovine serum albumin, 15% (w/v) glycerol,
15% (v/v) dimethyl sulfoxide and 0.1% (w/v) Triton X-100 for
1 hour at 30°C. The reaction was extracted with phenol-
chloroform and precipitated with ethanol. Plasmids that had
undergone a concerted integration of two oligonucleotides (and
therefore linear) were separated by horizontal agarose gel elec-
trophoresis and purified. The five-base gap resulting from the
transposition was repaired by nick translation with Taq DNA
polymerase. The resulting molecules were cleaved with MluI,
recircularized using T4 DNA ligase, and transformed into E.
coli strain DH10B by electroporation. The resulting library
contained over 450,000 independent transformants, each with
the 15 bp insertion containing the MluI recognition sequence
located at a random position in the pBabeCCR5-HA plasmid
(see Figs. 1 and 2).
Cells and vector supernatants
293T cells were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM) supplemented with 10% fetal calf
serum (FCS, from Gibco-BRL) and penicillin-streptomycin.
Hos.T4 cells which express human CD4 under the control of
an SV40 promoter were a gift of N. Landau and were
maintained in complete DMEM supplemented with 40
g/ml mycophenolic acid (MPA, Sigma) with xanthine and
hypoxanthine. Hos.T4.CCR5 cells that express both CD4
and wild-type CCR5 were a gift of D. Littman and were
maintained in 5 g/ml puromycin (Sigma).
Pseudotyped HIV vector supernatants were produced by
calcium-phosphate co-transfection of 293T cells (Sutton et
al., 1998) with pHIV-blasti and the relevant envelope ex-
pression construct, titered on Hos.T4.CCR5 cells using
complete DMEM supplemented with 10 g/ml blasticidin S
(Invitrogen). HIV-IRES-eYFP (VSV G) was prepared sim-
ilarly, 1 ml of supernatant was added to targets (HOS.T4
cells expressing either wt or mutant CCR5) in 12-well
plates, and 72 h later cells were subjected to flow cytometry,
gating on the eYFP  cells. HIV-Neo (ADA) was similarly
prepared, and 72 h after transduction, cells were positively
selected by passaging at a ratio of 1:10 in complete
DME supplemented with 1.0 mg/ml G418 (Invitrogen).
Pseudotyped MLV vector supernatant was produced by
calcium-phosphate co-transfection of 293T cells using
pHIT60, pME VSV G, and the mutant pBabeCCR5-HA
library or appropriate MLV vector construct. It was titered
using Hos.T4 cells as targets and also stored at 80°C.
Sorting for surface expression
Approximately 5 107 HOS.T4 cells were transduced
with 2.4 106 IU of the pseudotyped MLV stock described
above (m.o.i.0.05), selected in DMEM containing both
MPA and puromycin, and resistant colonies were pooled
and expanded. Approximately 4  107 cells were incubated
for 60 min at 4°C with 50 g of anti-HA mouse monoclonal
antibody 12CA5 (Boehringer-Mannheim) in PBS contain-
ing 2% FCS (PBS-FCS). Cells were washed three times in
PBS-FCS and bound to goat anti-mouse-coated magnetic
beads (Miltenyi-Biotec). Cells and beads were then applied
to a midi-MACS column (Miltenyi-Biotec). After washing
extensively, bound cells were eluted according to the man-
ufacturer’s instructions.
Recovered cells were expanded in complete DMEM sup-
plemented with MPA and puromycin. Flow cytometry was
performed by staining approximately 106 cells using 2 g of
12CA5 and goat anti-mouse-fluorescein isothiocyanate
(FITC) conjugate as a secondary antibody and analyzing
them on a FACScan (Becton-Dickinson) using CellQuest
software. Gates were established at the 1% level using
cells stained with the secondary antibody alone.
Genetic footprinting
Positively sorted cells above were independently trans-
duced with at least 106 IU of HIV-blasti(VSV G), HIV-
blasti (ADA), HIV-blasti (BaL), and HIV-blasti (SF162).
Transduced cells were selected in complete DMEM con-
taining 10 g/ml blasticidin S, and expanded. Genomic
DNA from approximately 2.5  107 cells was prepared by
SDS-proteinase K lysis and phenol:chloroform extraction.
Nested PCR was performed starting with 0.8 g of genomic
DNA (approximately 100,000 cell equivalents) using the
initial primer pair 5-GACCCTCCCTTTATCCAGCCCT-
CACTCCTT-3 (Gag-U) and 5-CCGTGGGCTTGTAC-
TCGGTCATGGTAAGCT-3 (Puro-L). Conditions using 5
U of Taqpluslong (Boehringer-Mannheim) were 40 cycles
of 94°C for 30 sec, 62°C for 30 sec, and 68° C for 90 sec to
obtain a 1.4 kb product. Ten–20 ng of this product was used
for the subsequent PCR reaction, using the following primer
pairs (one of which was 5 end-labeled with biotin and the
other 32-P): 5-TTATACATCGGAGCCCTGCCAAA-3
(281U, 3 end at position 82) and 5-AGCAAACACAG-
CATGGACGACAG-3 (625L, 3 end at position 404), total
length 367 bp; 5-CCCTCCCTTTATCCAGCCCTCAC-3
(BgagU) and 5-TGGCCAGGTTGAGCAGGTAGATG-3
(437L, 3 end at position 216), approximate total length 280
bp); 281U and 5-ACGCAAACACAGCCACCACCC-
AAGT-3 (693B, 3 end at position 472), total length 437
bp; 5-GTCGTCCATGCTGTGTTTGCTTT-3 (627U, 3
end at position 428) and 5-GCCCTGTGCCTCTTCTTCT-
CATT-3 (915L, 3 end at position 694), total length 311;
and 5-GGTGTCGAAATGAGAAGAAGAGG-3 (907U,
3 end at position 708) and 5-GGGACTTTCCACCCTA-
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ACTG-3 (1460L), approximate length 450 bp. Reaction
conditions were 15 cycles of 94°C for 30 sec, 62°C for 30
sec, and 72°C for 30 sec using 5 U Taq DNA polymerase.
Full-length PCR products were gel-isolated after size sepa-
ration by horizontal agarose gel electrophoresis and then
bound to streptavidin-agarose beads (SIGMA). After wash-
ing unbound material, beads were incubated with 10 U Mlu
I for 60 min at 37°C. Beads were pelleted by centrifugation,
and released DNA in the supernatant was precipitated with
ethanol using glycogen as carrier. Mlu I-cleaved PCR prod-
ucts were electrophoresed on 40 cm 7M urea-6% polyacryl-
amide 0.4mm sequencing gels, along with the homologous
dideoxy sequence. For quantitation of specific products,
Cerenkov counts were obtained for the full length PCR
products prior to binding to streptavidin-agarose beads (for
normalization purposes), and individual bands were quan-
titated using a Betagen blot analyzer system.
Construction of mutations in the fourth ECD of CCR5
and analysis of surface expression
4ECD-1 was constructed by PCR using pBabeCCR5-HA
as a template with the following primers 5-GGG-
AATTCGGGCATATGCAGGTGACAGAGACTCTTGG-3
(Eco 4U) and 5-GGGTCGACTCACAAGCCCACA-
GATATTTCCTG-3 (Eco 4L). The300 bp product was first
cloned into pCR 2.1-TOPO (Invitrogen), sequence confirmed,
and then directionally ligated into pBabeCCR5-HA pre-
cleaved with Eco RI and Sal I. 4ECD-2 was constructed by
cleaving 4ECD-1 with Eco RI and Nde I and inserting a duplex
oligonucleotide, with top strand sequence 5-AATT-
CAATAATTGCAGTAGCTCTAACAGGTTGGACCAAG-
CTCA-3. 4ECD-3 was constructed by cleaving 4ECD-1 with
Eco RI and Nde I and inserting a duplex oligonucleotide with
top s t rand sequence of 5  -AATTCTTTGGCC-
TGAATAATTGCAGTAGCTCTAACAGGTTGGACCAAG-
CTCA-3. 4ECD-4 was constructed by PCR using pBa-
beCCR5-HA as a template and the following primers: 5-GG-
GAATTCAATAATTGCAGTAGCTCTAACAGGTTGG-3
and the above-mentioned Eco 4L primer. The 285 bp prod-
uct was cloned into pBabeCCR5-HA as described for 4ECD-1.
4ECD-5 and 4ECD-6 were constructed by cleaving pBa-
beCCR5-HA with Eco RI and non-directionally ligating a
duplex oligonucleotide with top strand sequence of 5-
AATTGTCGACTG- 3. Both forward and reverse orientation
clones were confirmed by DNA sequencing. The amino acid
sequences of the mutant ECDs are shown in Table 1.
To examine cell surface expression of the 4ECD mutants,
HOS.CD4 cells were transduced with either pBabeCCR5-HA
or pBabeCCR5-HA-4ECD-6, both pseudotyped with VSV G.
Stable transductants were selected using DME complete me-
dium supplemented with 5 g/ml puromycin. For surface
staining, washed cells were incubated with PE-conjugated anti-
human CCR5 mouse monoclonal antibody (FAB182P, R&D
Systems) according to the manufacturer’s recommendations
and analyzed on a Becton-Dickinson FACScan. Gating was
established so that only 0.1% of the HOS.CD4 parental cells
were positive.
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